Separable Nerve Stimulator Housing for Disposable Tremor Interfaces

The patent introduces peripheral nerves as an intermediary target between the external stimulator and the brain's tremor-generating circuits. By stimulating peripheral nerves (e.g., median, ulnar, radial nerves) rather than directly stimulating the brain, the system achieves tremor reduction while avoiding invasive brain surgery. The peripheral nerves serve as a mediator that can be accessed through minimally invasive or non-invasive means, thereby reducing surgical risks while maintaining therapeutic effectiveness.

The patent replaces the mechanical/invasive deep brain stimulation system with an electrical/chemical stimulation system applied to peripheral nerves. Instead of using mechanical surgical implants in the brain, the system uses electrical or chemical stimuli delivered to peripheral nerves, which can be achieved through less invasive methods such as peripheral nerve blocks, epidural spaces, or even transcutaneous approaches, thereby eliminating the need for highly invasive brain surgery.

The patent replaces the chemical/pharmaceutical approach with an electrical or mechanical stimulation approach. Instead of using drugs that chemically modulate neural activity and cause systemic side effects, the system uses electrical or chemical stimuli applied locally to peripheral nerves. This localized approach avoids the systemic side effects associated with oral or intravenous medications while achieving comparable or superior tremor reduction through direct neural stimulation.

The patent applies stimulation locally to specific peripheral nerves rather than systemically through pharmaceutical drugs. By targeting specific peripheral nerves (such as the median nerve in the arm or leg nerves in the lower extremity) with localized electrical or chemical stimuli, the system achieves tremor reduction in the affected area without the widespread side effects that occur with systemic medication. This localized approach allows for precise treatment with minimal systemic absorption and associated adverse effects.

The patent addresses the limited duration of action by implementing continuous or repeated stimulation protocols. The system can deliver stimulation continuously during the treatment period and may be applied multiple times throughout the day to maintain tremor reduction. The peripheral nerve stimulation can be repeated at intervals to ensure continuous therapeutic effect, thereby overcoming the transient nature of single administrations and providing sustained tremor control throughout the day.

The patent employs preliminary action by administering stimulation before tremor episodes occur or by using priming protocols that prepare the neural system for extended response. The stimulation can be applied in advance to prime the peripheral nerve pathways, and the effects may be sustained through carryover or priming effects that extend the duration of action beyond the immediate stimulation period, thereby reducing the frequency of repeated treatments needed.